C-反应蛋白单克隆抗体,Anti-CRP(C11F2)抗体
- 产地:中国大陆
- 供应商:上海博研生物科技有限公司
- 供应商报价:电议
- 标签:C-反应蛋白单克隆抗体,Anti-CRP(C11F2)抗体,生物试剂,生化试剂,供应C-反应蛋白单克隆抗体,Anti-CRP(C11F2)抗体,博研生物科技有限公司上海分公司
博研生物抗体售前、售中、售后免费技术服务,欢迎致电索说明书
客服电话:021 60340850 021 60340830 021 60340820
客服QQ :827774711 349199432 372584443
产品名称 C-反应蛋白单克隆抗体,Anti-CRP(C11F2)抗体
产品编号 BYk-0391M
相关标记 HRP Biotin Gold RBITC AP FITC Cy3 Cy5 Cy5.5 Cy7 PE PE-Cy3 PE-Cy5 PE-Cy5.5
PE-CY7 APC Alexa Fluor 350 Alexa Fluor 488 Alexa Fluor 555 Alexa Fluor 647
浓 度 1mg/1ml
抗体来源 Rabbit OR MOUSE
克隆类型 polyclonal or monoclonal
产品类型 一抗
产品用途 科研实验,用于免疫组化实验,WB实验、IF、IP、ELISA实验,相应的标记抗体有HRP标记抗体,FITC标记,BIO等。
性 状 Lyophilized or Liquid
亚 型 IgG
C-反应蛋白单克隆抗体,Anti-CRP(C11F2)抗体保存条件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
C-反应蛋白单克隆抗体,Anti-CRP(C11F2)抗体产品说明:
C Reactive Protein is a major acute phase reactant synthesized primarily in the liver hepatocytes. It is a pentraxin (cyclic pentameric protein) compound of five identical nonglycosylated subunits of 206 amino acids each (m.w. 24 kDa), that are bound noncovalently to form the physiologic CRP molecule (m.w. 117.5 kDa). C Reactive Protein mediates activities associated with preimmune nonspecific host resistance. It is opsonic, an initiator of the classical complement cascade and an activator of monocytes/macrophages. CRP also binds to several nuclear components including chromatin, histones and snRNP, suggesting that it may play a role as a scavenger during cell necrosis. Studies have revealed that among other markers of inflammation, CRP shows the strongest association with cardiovascular events. Many clinical studies demonstrated that coronary mortality among patients with unstable angina and elevated CRP is significantly higher comparing with the patients without elevated CRP. Measurements of C reactive protein (hsCRP) in the patients with ischemic heart disease provide a novel method for detecting individuals at high risk of plaque rupture.